You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome, look for clinical trials, and connect with others living with it — all in one place.
Open the full Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome hub →Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome is a rare condition. Also known as Atherosclerosis-hearing loss-diabetes-epilepsy-nephropathy syndrome, Feigenbaum-Bergeron-Richardson syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:1192 · OMIM 209010 · ICD-10 I70.9 · GARD 0002279
Start by learning the basics from an authoritative source, find a specialist or center that sees Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome, filtered to your area.
Tomeko shows live, recruiting studies for Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome from ClinicalTrials.gov on the hub.